Background: Oral antipsychotic medications (OAMs) are frequently prescribed to patients with bipolar I disorder (BD-1) for symptom control. A cross-sectional survey examined side effects ...
Abstract: Background: People living with bipolar I disorder (BD-I) have a higher risk of obesity than the general population. While outcomes associated with obesity are well documented in...
This study used qualitative interviews to understand the patient experience of narcolepsy (types 1[NT1]=12 and 2 [NT2]=10). Many participants received a narcolepsy diagnosis at least 10 y...
This pooled post hoc analysis compared the effects of a combination of olanzapine and samidorphan (OLZ/SAM) versus olanzapine on body weight after 12 weeks of treatment in patients with s...
Among patients with schizophrenia (SZ) and bipolar I disorder (BD-I) treated with second-generation antipsychotics (SGAs), clinically-significant weight gain (CSWG) and treatment interrup...